Atopic Dermatitis
Atopic dermatitis (AD) is a chronic skin condition that causes dry, itchy, and inflamed skin. It often appears in flare-ups and can be triggered by various factors, leading to discomfort and skin irritation.
Atopic Dermatitis: RO7790121 Treatment Study
We are testing a new medication, RO7790121, for people with moderate to severe atopic dermatitis. The study aims to see if it can significantly improve skin symptoms compared to a placebo.
≤5 visitsEfficacy phase (II)Partially RemoteInvestigational MedicinesInjectionAllergologyDermatology
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you diagnosed with moderate to severe atopic dermatitis (AD) by a dermatologist at least 1 year ago?
- Do you have at least 10% of your body affected by atopic dermatitis?
- Are you currently using a simple, additive-free moisturizer every day?
- Have you taken any oral or injected corticosteroids in the last 4 weeks?
- Have you had any active infections that required treatment in the last 4 weeks?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Ro7790121
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
CHU Besancon
Onco-dermatology
Nantes, France
Assistance Publique Hopitaux De Paris
Dermatology
Quinze-Vingts, France
Centre Hospitalier Universitaire Rouen
Onco-dermatology
Rouen, France
Sponsor: F. Hoffmann-La Roche AG
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.